Federal Register / Vol. 72, No. 34 / Wednesday, February 21, 2007 / Notices 7901 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, RFA AG06–

008. 

Date: March 2, 2007. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Alicja L. Markowska, PhD, 

DSC, National Institute on Aging, National 

Institutes of Health, 7201 Wisconsin Avenue, 

Suite 2C212, Bethesda, MD 20892, 301–496–

9666, markowsa@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Initial Review Group, Neuroscience of 

Aging Review Committee. 

Date: March 12–13, 2007. 

Time: 5 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Watergate Hotel, 2650 Virginia 

Avenue NW., Washington, DC 20037. 

Contact Person: Louise L. Hsu, PhD, Health 

Scientist Administrator, Scientific Review 

Office, National Institute on Aging, Gateway 

Building, 7201 Wisconsin Avenue/Suite 

2C212, Bethesda, MD 20892, (301) 496–7705, 

hsul@exmur.nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: February 9, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–765 Filed 2–20–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging, Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Age, GeneEnvironment Susceptibility—The Rejjavik 

Study II (Ages—RSII). 

Date: February 13, 2007 

Time: 9 a.m. to 10 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20814, (Telephone 

Conference Call). 

Contact Person: Alicja L. Markowska, PhD., 

DSC National Institute on Aging, National 

Institutes of Health, 7201 Wisconsin Avenue, 

Suite 2C212, Bethesda, MD 20892, 301–496–

9666, markowsa@nia.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institues of Health, HHS) 

Dated: February 9, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–766 Filed 2–20–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Stress, Social Anxiety and Role 

Strain in Adults. 

Date: February 16, 2007. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Gayle M. Boyd, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3028–D, 

MSC 7759, Bethesda, MD 20892, 301–451–

9956, gboyd@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group, Molecular 

Neuropharmacology and Signaling Study 

Section. 

Date: February 21–22, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Jurys Washington Hotel, 1500 New 

Hampshire Avenue, NW., Washington, DC 

20032. 

Contact Person: Carole L. Jelsema, PhD, 

Chief and Scientific Review Administrator, 

MDCN IRG, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 4176, MSC 7850, Bethesda, MD 

20892, (301) 435–1248, jelsemac@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Psychological Sequelae of Diagnosis. 

Date: February 22, 2007. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Lee S. Mann, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3186, 

MSC 7848, Bethesda, MD 20892, 301–435–

0677, mannl@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Fellowships 

Review: Sensory, Motor and Cognitive 

Neuroscience. 

Date: February 27, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Jurys Washington Hotel, 1500 New 

Hampshire Ave., NW., Washington, DC 

20036. 

Contact Person: Judith A. Finkelstein, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5178, 

MSC 7844, Bethesda, MD 20892, 301–435–

1249, finkelsj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PET Imaging 

Overflow. 

Date: February 28, 2007. 

Time: 4 p.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Xiang-Ning Li, MD, PhD, 

Scientific Review Administrator, Center for 


rmajette on PROD1PC67 with NOTICES
7902 Federal Register / Vol. 72, No. 34 / Wednesday, February 21, 2007 / Notices 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5112, 

MSC 7854, Bethesda, MD 20892, 301–435–

1744, lixiang@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SBIR/STTR 

Risk Prevention and Health Behaviors. 

Date: March 1, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz-Carlton Hotel, 1700 Tysons 

Boulevard, McLean, VA 22102. 

Contact Person: Claire E. Gutkin, PhD, 

MPH, Scientific Review Administrator, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 3138, MSC 7759, Bethesda, MD 20892, 

301–594–3139, gutkincl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SBIR/STTR 

Early Childhood Behaviors and Adolescent/ 

Adult Addictions. 

Date: March 2, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz-Carlton Hotel, 1700 Tysons 

Boulevard, McLean, VA 22102. 

Contact Person: Claire E. Gutkin, PhD, 

MPH, Scientific Review Administrator, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 3138, MSC 7759, Bethesda, MD 20892, 

301–594–3139, gutkincl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, NIDDK PAR 

06 113. 

Date: March 5, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza, 8777 Georgia Avenue, 

Silver Spring, MD 20910. 

Contact Person: Daniel F. McDonald, PhD, 

Scientific Review Administrator, Chief, Renal 

and Urological Sciences IRG, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4214, 

MSC 7814, Bethesda, MD 20892, (301) 435–

1215, mcdonald@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Radiation 

Therapy and Biology SBIR/STTR. 

Date: March 5–6, 2007. 

Time: 8 a.m. to 11 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Bo Hong, PhD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 6194, MSC 7804, 

Bethesda, MD 20892, 301–435–5879, 

hongb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Drug and 

Discovery and Development Special 

Emphasis Panel. 

Date: March 5, 2007. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: Sergei Ruvinov, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4158, 

MSC 7806, Bethesda, MD 20892, 301–435–

1180, ruvinser@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Fellowships: Diversity Program. 

Date: March 7, 2007. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Mt. Vernon, Bethesda, MD 20814. 

Contact Person: Abdelouahab Aitouche, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2183, 

MSC 7818, Bethesda, MD 20892, 301–435–

2365, abdelouahaba@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Diabetes 

and Obesity. 

Date: March 7, 2007. 

Time: 10 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Krish Krishnan, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6164, 

MSC 7892, Bethesda, MD 20892, (301) 435–

1041, krishnak@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Immune 

Mechanisms. 

Date: March 7, 2007. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Jian Wang, PhD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 4095D, MSC 7812, 

Bethesda, MD 20892, (301) 435–2778, 

wangjia@csr.nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group, 

Behavioral and Social Consequences of HIV/ 

AIDS Study Section. 

Date: March 8, 2007. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westwood on Wilshire, 10740 

Wilshire Blvd, Los Angeles, CA 90024. 

Contact Person: Mark P. Rubert, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, 301–435–

1775, rubertm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Drug Use 

and Lifestyle in Adolescents and Adults. 

Date: March 8, 2007. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Beacon Hotel and Corporate 

Quarters, 1615 Rhode Island Avenue, NW, 

Washington, DC 20036. 

Contact Person: Gayle M. Boyd, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3028–D, 

MSC 7759, Bethesda, MD 20892, 301–451–

9956, gboyd@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Development of Methods of In Vivo Imaging 

and Bioengineering Research. 

Date: March 12–13, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW, 

Washington, DC 20015. 

Contact Person: Alexandra M. Ainsztein, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5144, 

MSC 7840, Bethesda, MD 20892, 301–451–

3848, ainsztea@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Auditory 

System Development. 

Date: March 13, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: John Bishop, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5180, 

MSC 7844, Bethesda, MD 20892, (301) 435–

1250, bishopj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Mesoderm 

and Mesenchymal Stem Cells. 

Date: March 13, 2007. 

Time: 3 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: 6701 Rockledge Drive, Bethesda, MD 

20892 (Telephone Conference Call). 

Contact Person: Chhanda L. Ganguly, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7802, Bethesda, MD 20892 (301) 435–

1739, gangulyc@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Neurogenetics and Neurogenomics. 

Date: March 14, 2007. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Watergate, 2650 Virginia 

Avenue, NW., Washington, DC 20037. 

Contact Person: Robert C. Elliott, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3130, 

MSC 7850, Bethesda, MD 20892, 301–435–

3009, elliotro@csr.nih.gov. 


rmajette on PROD1PC67 with NOTICES
Federal Register / Vol. 72, No. 34 / Wednesday, February 21, 2007 / Notices 7903 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Clocks in 

Arabidopsis and Neurospora. 

Date: March 14, 2007. 

Time: 9 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Lawrence Baizer, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4152, 

MSC 7850, Bethesda, MD 20892 (301) 435–

1257, baizerl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business: Assays, Devices, and Instruments. 

Date: March 14–15, 2007. 

Time: 9 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Geoffrey White, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5148, 

MSC 7849, Bethesda, MD 20892, 301–435–

2417, whitege@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflicts in Motor Function, Language, and 

Cognition. 

Date: March 14, 2007. 

Time: 1 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Luci Roberts, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3188, 

MSC 7848, Bethesda, MD 20892, (301) 435–

0692, roberlu@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Cell and 

Molecular Biology of Kidney Members 

Conflict Review. 

Date: March 14, 2007. 

Time: 3 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Krystyna E. Rys-Sikora, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4016J, 

MSC 7814, Bethesda, MD 20892, 301–451–

1325, ryssokok@csr.nih.gov. 

Name of Committee: AIDS and Related 

Research Integrated Review Group, AIDS 

Discovery and Development of Therapeutics 

Study Section. 

Date: March 15, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Washington, Pennsylvania 

Ave at 15th Street, NW., Washington, DC 

20004. 

Contact Person: Shiv A. Prasad, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5220, 

MSC 7852, Bethesda, MD 20892, 301–443–

5779, prasads@csr.nih.gov. 

Name of CommittCee: AIDS and Related 

Research Integrated Review Group, 

NeuroAIDS and other End-Organ Diseases 

Study Section. 

Date: March 15, 2007. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Washington, DC, 

1515 Rhode Island Ave., NW., Washington, 

DC 20005. 

Contact Person: Ranga V. Srinivas, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5216, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1167, srinivar@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business: Digestive Sciences and 

Bioengineering. 

Date: March 15, 2007. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Bonnie L. Burgess-Beusse, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2191C, 

MSC 7818, Bethesda, MD 20892, 301–435–

1783, beusseb@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Chemical 

and Biophysics SBIR/STTR Panel. 

Date: March 15, 2007. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Beacon Hotel and Corporate 

Quarters, 1615 Rhode Island Avenue, NW., 

Washington, DC 20036. 

Contact Person: Sergei Ruvinov, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4158, 

MSC 7806, Bethesda, MD 20892, 301–435–

1180, ruvinser@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Fellowship: 

Biophysical and Biochemical Sciences. 

Date: March 15–16, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Churchill Hotel, 1914 Connecticut 

Avenue, NW., Washington, DC 20009. 

Contact Person: James W. Mack, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 40401, 

MSC 7806, Bethesda, MD 20892, 301–435–

1747, mackj2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Biobehavioral Regulation, Learning and 

Ethology. 

Date: March 15, 2007. 

Time: 10:30 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Cheri Wiggs, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3180, 

MSC 7848, Bethesda, MD 20892, (301)–435–

1261, wiggsc@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Genetics of 

Hypertension. 

Date: March 15, 2007. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Ai-Ping Zou, PhD, MD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7814, Bethesda, MD 20892, 301–435–

1777, zouai@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, CLHP and 

NSCF Member SEP. 

Date: March 15, 2007. 

Time: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Ellen K. Schwartz, EDD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3168, 

MSC 7770, Bethesda, MD 20892, 301–435–

0681, schwarte@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group, Biomedical 

Computing and Health Informatics Study 

Section. 

Date: March 15–16, 2007. 

Time: 7 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Bill Punnag, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5124, 

MSC 7854, Bethesda, MD 20892, (301) 435–

1177, bunnagb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Cardiovascular and Sleep Epidemiology 

Member Conflicts. 

Date: March 15, 2007. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Sandra L. Melnick, DRPH, 

Scientific Review Administrator, Center for 


rmajette on PROD1PC67 with NOTICES
7904 Federal Register / Vol. 72, No. 34 / Wednesday, February 21, 2007 / Notices 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3028D, 

MSC 7770, Bethesda, MD 20892, 301–435–

1251, melnicks@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 8, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–762 Filed 2–20–07; 8:45 am] 

BILLING CODE 4140–07–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: The Use of Adenovirus 

Vectors for the Development of 

Vaccines Against Human 

Immunodeficiency Virus and Other 

Infectious Agents 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

Part 404.7(a)(1)(i), that the National 

Institutes of Health (NIH), Department 

of Health and Human Services (HHS), is 

contemplating the grant of an exclusive 

patent license to practice the inventions 

embodied in Patent Cooperation Treaty 

Application No. PCT/US02/27592 filed 

August 29, 2002 and United States 

National Stage Application Serial No. 

10/487,974 filed February 27, 2004, 

entitled ‘‘New Adenovirus Type 7 

Vectors’’ [HHS Reference No. E–236–

2001/0], and United States Patent 

Application Serial No. 11/282,319 filed 

November 17, 2005, entitled ‘‘Improved 

Replication-Competent Adenovirus 

Vectors’’ [HHS Reference No. E–203–

2004/0], to PaxVax, Inc., which has 

offices in Menlo Park, CA. The patent 

rights in these inventions have been 

assigned and/or exclusively licensed to 

the Government of the United States of 

America. 

The prospective exclusive license 

territory may be the United States of 

America, and the field of use may be 

limited to the development of vaccines 

against human immunodeficiency virus, 

human papillomavirus, influenza, 

malaria, and tuberculosis. 

DATES: Only written comments and/or 

applications for a license which are 

received by the NIH Office of 

Technology Transfer on or before April 

23, 2007 will be considered. 

ADDRESSES: Requests for copies of the 

patent application, inquiries, comments, 

and other materials relating to the 

contemplated exclusive license should 

be directed to: Susan Ano, Ph.D., 

Technology Licensing Specialist, Office 

of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, MD 

20852–3804; Telephone: (301) 435–

5515; Facsimile: (301) 402–0220; E-mail: 

anos@mail.nih.gov. 

SUPPLEMENTARY INFORMATION: The 

subject application addresses two (2) 

technologies related to specific 

techniques for producing adenoviral 

vectors and application of such vectors 

for gene transfer, vaccine development 

and therapeutics. Use of the present 

technologies in the prevention and/or 

treatment of disease, especially human 

immunodeficiency virus (HIV), is the 

primary focus of the current subject 

inventions. 

The first technology (HHS Reference 

No. E–236–2001/0) describes a cosmid 

adenoviral serotype 7 (Ad7) vector for 

use in the prevention and/or treatment 

of HIV–1. This invention includes 

methods for producing and 

administering both replicationcompetent and incompetent Ad7. The 

cosmid Ad7 vector includes an Ad7 

genome that can be modified to express 

specific nucleic acid sequences for 

production of a desired protein or 

epitope such as an HIV–1 gene product. 

This system may be used to generate 

proteins or epitopes of infectious agents 

for stimulation of desired immunogenic 

responses. 

The second invention (HHS Reference 

No. E–203–2004/0) discloses 

improvements upon replicationcompetent Ad vectors, which serve to 

produce high level expression of any 

gene of interest, i.e., a transgene. This 

system incorporates a novel hybrid gene 

regulatory unit comprising a CMV 

promoter and an adenovirus tripartite 

leader sequence for regulation of 

transgene expression. Additionally, the 

present disclosure provides methods of 

producing and administering the 

described adenoviral expression vectors, 

containing the nucleic acid sequence of 

significant HIV–1 proteins as transgenes 

for stimulation of an immune response 

to HIV–1. 

The prospective exclusive license will 

be royalty bearing and will comply with 

the terms and conditions of 35 U.S.C. 

209 and 37 CFR part 404.7. The 

prospective exclusive license may be 

granted within ninety (90) days from the 

date of this published notice, unless the 

NIH receives written evidence and 

argument that establishes that the grant 

of the license would not be consistent 

with the requirements of 35 U.S.C. 209 

and 37 CFR part 404.7. 

Applications for a license in the field 

of use filed in response to this notice 

will be treated as objections to the grant 

of the contemplated exclusive license. 

Comments and objections submitted to 

this notice will not be made available 

for public inspection and, to the extent 

permitted by law, will not be released 

under the Freedom of Information Act, 

5 U.S.C. 552. 

Dated: February 12, 2007. 

Steven M. Ferguson, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. E7–2883 Filed 2–20–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF THE INTERIOR 

Fish and Wildlife Service 

Conference of the Parties to the 

Convention on International Trade in 

Endangered Species of Wild Fauna 

and Flora (CITES); Fourteenth Regular 

Meeting; Provisional Agenda; 

Announcement of Public Meeting 

AGENCY: Fish and Wildlife Service, 

Interior. 

ACTION: Notice. 

SUMMARY: We, the United States, as a 

Party to the Convention on International 

Trade in Endangered Species of Wild 

Fauna and Flora (CITES), will attend the 

fourteenth regular meeting of the 

Conference of the Parties to CITES 

(CoP14) in The Hague, The Netherlands, 

June 3–15, 2007. Currently, the United 

States is developing its negotiating 

positions on proposed resolutions, 

decisions, and amendments to the 

CITES Appendices (species proposals), 

as well as other agenda items that have 

been submitted by other Party countries 

and the CITES Secretariat for 

consideration at CoP14. With this notice 

we announce the provisional agenda for 

CoP14, solicit your comments on the 

items on the provisional agenda, and 

announce a public meeting to discuss 

the items on the provisional agenda. 

DATES: The public meeting will be held 

on April 9, 2007, at 1:30 p.m. In 

developing the U.S. negotiating 

positions on proposed resolutions, 

decisions, and species proposals, and 

other agenda items submitted by other 

Party countries and the CITES 

Secretariat for consideration at CoP14, 

we will consider written information 


rmajette on PROD1PC67 with NOTICES